Cargando…

The landscape of UBE2S in hepatocellular carcinoma: Prognostic significance, immuno-oncology feature and drug response

Detalles Bibliográficos
Autores principales:	Qiu, Lipeng, Wang, Yue, Li, Zhihuan, Tu, Zhigang, Liu, Hanqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Chongqing Medical University 2022
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201602/ https://www.ncbi.nlm.nih.gov/pubmed/37223535 http://dx.doi.org/10.1016/j.gendis.2022.04.010

Ejemplares similares

Genetic landscape and clinical significance of cuproptosis-related genes in liver hepatocellular carcinoma
por: Hu, Dingtao, et al.
Publicado: (2023)

Rapidly Evolving Landscape and Future Horizons in Hepatocellular Carcinoma in the Era of Immuno-Oncology
por: Kang, Sandra Mirie, et al.
Publicado: (2022)

Transient HSP90 inhibition enhances the sensitivity of mantle cell lymphoma to poly (ADP-ribose) polymerase (PARP) inhibitors
por: Shi, Chaowen, et al.
Publicado: (2023)

Immune landscape and biomarkers for immuno-oncology in colorectal cancers
por: Bae, Jeong Mo, et al.
Publicado: (2020)

Insights into immuno-oncology drug development landscape with focus on bone metastasis
por: Kähkönen, Tiina E., et al.
Publicado: (2023)

Immuno-Oncology
por: Chaudhuri, Swapna
Publicado: (2017)

The landscape of m6A regulators in esophageal cancer: molecular characteristics, immuno-oncology features, and clinical relevance
por: Li, Zhe, et al.
Publicado: (2022)

Circulating fibroblasts present neutrophil-like features in severe COVID-19 cases revealed by single-cell landscape analyses
por: Liu, Xiangjun, et al.
Publicado: (2023)

The New Immuno-Oncology-Based Therapies and Their Perspectives in Hepatocellular Carcinoma
por: Merle, Philippe
Publicado: (2021)

The evolving landscape of predictive biomarkers in immuno‐oncology with a focus on spatial technologies
por: Sadeghi Rad, Habib, et al.
Publicado: (2020)

Evolving landscape and academic attitudes toward the controversies of global immuno‐oncology trials
por: Xu, Cheng, et al.
Publicado: (2021)

Immuno‐Oncology in China
por: Lu, Shun, et al.
Publicado: (2019)

Radiomics in immuno-oncology
por: Bodalal, Z., et al.
Publicado: (2021)

The Role of Radiation Oncology in Immuno‐Oncology
por: Meng, Xiangjiao, et al.
Publicado: (2019)

Multi-View Radiomics Feature Fusion Reveals Distinct Immuno-Oncological Characteristics and Clinical Prognoses in Hepatocellular Carcinoma
por: Gu, Yu, et al.
Publicado: (2023)

Integrative multi-platform meta-analysis of hepatocellular carcinoma gene expression profiles for identifying prognostic and diagnostic biomarkers
por: Gholizadeh, Maryam, et al.
Publicado: (2022)

Identification of TP53 mutation-associated prognostic genes and investigation of the immune cell infiltration in patients with hepatocellular carcinoma
por: Yang, Qijun, et al.
Publicado: (2023)

DEFECTIVE HUMAN IMMUNO‐DEFICIENCY VIRUS (HIV) PARTICLES PRODUCED BY CLONED CELLS OF HTLV‐I‐CARRYING MT‐4 CELLS PERSISTENTLY INFECTED WITH HIV
por: Ikuta, Kazuyoshi, et al.
Publicado: (1988)

The landscape of m(6)A regulators in small cell lung cancer: molecular characteristics, immuno-oncology features, and clinical relevance
por: Zhang, Chaoqi, et al.
Publicado: (2021)

Lights and Shadows in Immuno-Oncology Drug Development
por: Bergamino Sirvén, Milana, et al.
Publicado: (2021)

The perplexing role of immuno-oncology drugs in osteosarcoma
por: Smrke, Alannah, et al.
Publicado: (2021)

Clinicopathological significance and prognostic implications of Ube2v1 expression in colorectal cancer
por: Ma, Qiang, et al.
Publicado: (2023)

Targeting DNA-PKcs promotes anti-tumoral immunity via triggering cytosolic DNA sensing and inducing an inflamed tumor immuno-microenvironment in metastatic triple-negative breast cancer
por: Ma, Chao, et al.
Publicado: (2023)

Mevalonate Metabolism in Immuno-Oncology
por: Gruenbacher, Georg, et al.
Publicado: (2017)

Immuno-Oncology Essentials: An Overview
por: Hoffner, Brianna
Publicado: (2019)

Multiplex imaging in immuno-oncology
por: Zhao, Chen, et al.
Publicado: (2023)

Immuno-genomic landscape of osteosarcoma
por: Wu, Chia-Chin, et al.
Publicado: (2020)

Biliary Atresia Relevant Human Induced Pluripotent Stem Cells Recapitulate Key Disease Features in a Dish
por: Tian, Lipeng, et al.
Publicado: (2019)

Construction of a novel predictive model with seven metabolism-related genes for hepatocellular carcinoma by machine learning
por: Mou, Lisha, et al.
Publicado: (2023)

Human RNA Modifications Disease Database (HRMDD): A web resource for the molecular and clinical landscape of RNA modifications in human diseases
por: Wang, Jianjian, et al.
Publicado: (2022)

COVID-19 pandemic planning: considerations for radiation oncology medical physics
por: Whitaker, May, et al.
Publicado: (2020)

An analysis of the transcriptional landscape in hypoxia-treated primary nucleus pulposus cells
por: Peng, Zhicai, et al.
Publicado: (2023)

Challenges and Opportunities in Dose Finding in Oncology and Immuno‐oncology
por: Ji, Yan, et al.
Publicado: (2018)

Expression and clinical significance of UBE2V1 in cervical cancer
por: Ren, Zhishuai, et al.
Publicado: (2021)

Oncogenetic landscape and clinical impact of IDH1 and IDH2 mutations in T-ALL
por: Simonin, Mathieu, et al.
Publicado: (2021)

Statistical issues and challenges in immuno-oncology
por: Chen, Tai-Tsang
Publicado: (2013)

Immunotherapies and Combination Strategies for Immuno-Oncology
por: Barbari, Cody, et al.
Publicado: (2020)

Necroptosis in Immuno-Oncology and Cancer Immunotherapy
por: Sprooten, Jenny, et al.
Publicado: (2020)

Immuno-oncology for B-cell lymphomas
por: Choi, Yoon Seok
Publicado: (2021)

Virus-Based Immuno-Oncology Models
por: Sitta, Juliana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t3fdj8qo3m0ai60g5mtotk2e5v